- Home
- COGT vs OCFC Comparison
COGT vs OCFC Comparison
Compare COGT & OCFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COGT
- OCFC
- Stock Information
- Founded
- COGT 2014
- OCFC 1902
- Country
- COGT United States
- OCFC United States
- Employees
- COGT N/A
- OCFC N/A
- Industry
- COGT Biotechnology: Pharmaceutical Preparations
- OCFC Major Banks
- Sector
- COGT Health Care
- OCFC Finance
- Exchange
- COGT Nasdaq
- OCFC Nasdaq
- Market Cap
- COGT 895.8M
- OCFC 1.1B
- IPO Year
- COGT 2018
- OCFC 1996
- Fundamental
- Price
- COGT $8.03
- OCFC $18.76
- Analyst Decision
- COGT Buy
- OCFC Hold
- Analyst Count
- COGT 6
- OCFC 4
- Target Price
- COGT $14.17
- OCFC $21.00
- AVG Volume (30 Days)
- COGT 1.5M
- OCFC 322.8K
- Earning Date
- COGT 02-24-2025
- OCFC 01-23-2025
- Dividend Yield
- COGT N/A
- OCFC 4.26%
- EPS Growth
- COGT N/A
- OCFC N/A
- EPS
- COGT N/A
- OCFC 1.74
- Revenue
- COGT N/A
- OCFC $380,971,000.00
- Revenue This Year
- COGT N/A
- OCFC N/A
- Revenue Next Year
- COGT N/A
- OCFC $5.39
- P/E Ratio
- COGT N/A
- OCFC $10.77
- Revenue Growth
- COGT N/A
- OCFC N/A
- 52 Week Low
- COGT $4.28
- OCFC $14.03
- 52 Week High
- COGT $12.61
- OCFC $21.87
- Technical
- Relative Strength Index (RSI)
- COGT 46.50
- OCFC 53.25
- Support Level
- COGT $6.60
- OCFC $18.41
- Resistance Level
- COGT $8.72
- OCFC $19.30
- Average True Range (ATR)
- COGT 0.51
- OCFC 0.49
- MACD
- COGT 0.09
- OCFC 0.16
- Stochastic Oscillator
- COGT 67.45
- OCFC 73.00
About COGT Cogent Biosciences Inc.
Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with strong dependence on oncogenic KIT signaling.
About OCFC OceanFirst Financial Corp.
OceanFirst Financial Corp is engaged in the banking sector of the United States. It conducts the business of attracting retail and business deposits and investing them in loans, consisting of single-family, owner-occupied residential mortgage loans, and commercial real estate loans. The company's sole segment deals with the delivery of loan and deposit products to customers. The bank's revenues are derived principally from interest on its loans, and to a lesser extent, interest on its investment and mortgage-backed securities. The rest of its income is dependent on bank card services and wealth management services.